Skip to content

Analysis of clinical efficacy and safety of ELIF in the treatment of LSS by transforaminal approach and interlaminar approach

Analysis of clinical efficacy and safety of ELIF in the treatment of LSS by transforaminal approach and interlaminar approach

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060226
Enrollment
Unknown
Registered
2022-05-22
Start date
2022-05-12
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar spinal stenosis

Interventions

Endo-TLIF:transforaminal approach ELIF
interlaminar approach:interlaminar approach ELIF

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age: 40-80 years; 2. The patient has corresponding symptoms of spinal canal stenosis, including lumbar pain, radiation pain, intermittent claudication, sensory abnormalities, motor dysfunction and reflex abnormalities; 3. Imaging showed central spinal canal stenosis or lateral recess stenosis caused by various degenerative diseases such as intervertebral disc herniation and hypertrophy of ligamentum flavum at the lesion segment; 4. The clinical symptoms and signs are consistent with the imaging findings; 5. The severity of the disease has reached the standard of surgical treatment.

Exclusion criteria

Exclusion criteria: 1. Lumbar spinal stenosis caused by spinal diseases other than spinal degenerative diseases, such as spinal tumors; 2. Previous history of spinal surgery, or other spinal diseases, such as lumbar trauma, spinal infection, severe spinal deformity, ankylosing spondylitis, etc; 3. There are other diseases that may cause low back pain and lower limb dysfunction, such as intermittent claudication caused by lower limb arterial embolism, cerebrovascular accident, severe osteoarthritis or rheumatoid arthritis, or after total hip or knee replacement; 4. Serious medical diseases, such as severe cardiopulmonary insufficiency, severe osteoporosis, coagulation dysfunction, etc; 5. Nervous disorders or mental disorders, such as dementia and stroke.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale of low back pain;Japanese Orthopaedic Association Scores;Oswestry Disability Index;Visual analogue scale of lower extremity pain;

Secondary

MeasureTime frame
Fat infiltration of paraspinal muscle;position of cage;The angle of the cage relative to the long axis of the intervertebral space;facet joint bone removal rate;hidden blood loss;

Countries

China

Contacts

Public ContactXiaobing Jiang

The First Clinical Medical College of Guangzhou University of Traditional Chinese Medicine

spinedrjxb@sina.com+86 13632494486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026